Hi, Tuck
I have been watching things lately from the sidelines, waiting for the end of "Uncle Ben's Triggered Correction".<g>
Re: PDLI
It seems yesterday's L of 16.88 was a good entry point.
bigcharts.marketwatch.com
Albeit the stock isn't yet off from its near term downtrend & it needs to close above its June 6 H of 20.88 before it can close more of its May 3 downgap.(The attempted rally on May 8 didn't close even half of the gap.<g>)
bigcharts.marketwatch.com
Apparently. in spite of Mark McDade's optimistic letter to the shareholders on the annual report for 2005, dated May 1st, the resulst for the 1stQ (March) didn't come as expected.(Only $0.02/shr Vs. the expected $0.14/shr) & PDLI also lowered its income expectations from Roche & Biogen & cut its 2006 earnings expectations between $0.07 & $0.19/shr.Of course, that will be yet much better than the results on the red column since 2000.<g> But PDLI has also lowered its revenue expectations & the "analysts" have downgraded PDLI from "Strong Buy" to just "Buy".<g>
However, if Mark's goals for the next couple of years of moving forward Retavase, Busulfex, Cardene, Terlipressing, Nuvion & Ularitide come through, yesterday's L will have been indeed a good entry.<g>
PDLI still has a good institutional backing with Fidelity's FMR, Barclays, Oppenheimer, Amvescap, T.RowePrice, Calamos & Delaware Management Trust each reportedly holding stock valued in the tripple digits million $$$ .<g>
finance.yahoo.com
Once it closes its May 3 downgap & if we get a better market enviroment, it seems PDLI should get back to the middle 30s.<g>
bigcharts.marketwatch.com
RAGL
Bernard |
